Dermatology, Nasal Sprays Among Emerging OTC Switch Categories
This article was originally published in The Tan Sheet
Executive Summary
FDA threw the switch floodgates open with the NSURE initiative and it has fueled interest with the recent first-in-class switches of Nasacort and Oxytrol for Women. Likely categories for successful switches include dermatology, nasal sprays in allergy, sleep, migraine relief and cholesterol management.
You may also be interested in...
Galderma Acne Ingredient Switch Receives NDAC Review In April
FDA schedules an April 15 NDAC to consider whether data in Galderma's supplemental NDA support an acceptable risk/benefit profile for nonprescription use of adapalene gel 0.1.
Galderma Acne Ingredient Switch Receives NDAC Review In April
FDA schedules an April 15 NDAC to consider whether data in Galderma's supplemental NDA support an acceptable risk/benefit profile for nonprescription use of adapalene gel 0.1.
Galderma Acne Ingredient Switch Receives NDAC Review In April
FDA schedules an April 15 NDAC to consider whether data in Galderma's supplemental NDA support an acceptable risk/benefit profile for nonprescription use of adapalene gel 0.1.